Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives
Ema Ozaki,1 Matthew Campbell,1 Sarah L Doyle2,3 1Department of Genetics, 2Department of Clinical Medicine, School of Medicine, Trinity College Dublin, 3National Children's Research Centre, Our Lady's Children's Hospital Crumlin, Dublin, Ireland Abstract: The inflammasome is...
Guardado en:
Autores principales: | Ozaki E, Campbell M, Doyle SL |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/db090e7b71ab4be5a2c720688d371a9f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The role of the NLRP3 inflammasome in gout
por: Sarah R Kingsbury, et al.
Publicado: (2011) -
Inflammatory cytokines and atrial fibrillation: current and prospective views
por: Hadi AR Hadi, et al.
Publicado: (2010) -
Current perspectives on the role of IL-17 in autoimmune disease
por: Hisakata Yamada
Publicado: (2010) -
Spotlight on the NLRP3 inflammasome pathway
por: Groslambert M, et al.
Publicado: (2018) -
Progress and perspectives on the role of RPE cell inflammatory responses in the development of age-related macular degeneration
por: Suofu Qin, et al.
Publicado: (2008)